Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...

Cigarette smoke causes cancer primarily by damaging the DNA. A new study that mapped these damages has revealed that the way ...

Cutting-Edge Cardiac Research: Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac ...

Eli Lilly has been a terrific stock to own for the past five years, thanks to its excellent clinical and regulatory progress. The company's breakthroughs are paying off. In each of the past six ...

Knowing what to look for can help you identify a tick bite ... 60% to 70% of people with the disease would develop a rash like this, more recent evidence suggests that number may actually be ...

Song Park, MD, University of Washington Medicine, advocates for more user-friendly technology to support equitable skin cancer care access. The American Journal of Managed Care®’s Strategic ...

We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...

The phase 3 EMBARK trial has been evaluating the gene therapy in ambulatory boys aged four to seven years with a confirmed mutation in the DMD gene. Estimated to affect one in every 5,000 male births ...

Two years after receiving the gene therapy Elevidys (delandistrogene moxeparvovec-rokl), motor function continues to improve in boys with Duchenne muscular dystrophy (DMD) who entered a global ...

Elevidys, which is the only gene therapy for Duchenne muscular dystrophy on the market, delivers a gene that encodes microdystrophin, an engineered protein developed by Sarepta that it says can carry ...

Also Read: Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development Despite being one year older (average age 7.18 years) than those treated in Part 1 (average age 5.98 years ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...